315 related articles for article (PubMed ID: 19904612)
41. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA
J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
[TBL] [Abstract][Full Text] [Related]
42. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
Thomale UW; Stover JF; Unterberg AW
Zentralbl Neurochir; 2005 Aug; 66(3):126-32; discussion 132. PubMed ID: 16116555
[TBL] [Abstract][Full Text] [Related]
43. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
[TBL] [Abstract][Full Text] [Related]
44. Acromegaly with no pituitary adenoma and no evidence of ectopic source.
Khandelwal D; Khadgawat R; Mukund A; Suri A
Indian J Endocrinol Metab; 2011 Sep; 15 Suppl 3(Suppl3):S250-2. PubMed ID: 22029034
[TBL] [Abstract][Full Text] [Related]
45. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
Almeida JP; Ruiz-Treviño AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH
J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
[TBL] [Abstract][Full Text] [Related]
46. Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study.
Coopmans EC; Postma MR; Wolters TLC; van Meyel SWF; Netea-Maier R; van Beek AP; Neggers SJCMM
J Clin Endocrinol Metab; 2021 May; 106(6):1783-1792. PubMed ID: 33544833
[TBL] [Abstract][Full Text] [Related]
47. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
[TBL] [Abstract][Full Text] [Related]
48. Giant growth hormone-secreting pituitary adenomas from the endocrinologist's perspective.
Koylu B; Firlatan B; Sendur SN; Oguz SH; Dagdelen S; Erbas T
Endocrine; 2023 Mar; 79(3):545-553. PubMed ID: 36318446
[TBL] [Abstract][Full Text] [Related]
49. The clinical and biochemical spectrum of ectopic acromegaly.
Fainstein-Day P; Ullmann TE; Dalurzo MCL; Sevlever GE; Smith DE
Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101877. PubMed ID: 38413286
[TBL] [Abstract][Full Text] [Related]
50. Suprasellar pituitary adenomas: a 10-year experience in a single tertiary medical center and a literature review.
Zhu J; Wang Z; Zhang Y; Liu J; Li X; Deng K; Lu L; Yao Y
Pituitary; 2020 Aug; 23(4):367-380. PubMed ID: 32378170
[TBL] [Abstract][Full Text] [Related]
51. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
[TBL] [Abstract][Full Text] [Related]
52. Acromegaly due to an ectopic pituitary adenoma in the sphenoid sinus.
Gondim JA; Schops M; Ferreira E; Bulcão T; Mota JI; Silveira C
Acta Radiol; 2004 Oct; 45(6):689-91. PubMed ID: 15587430
[TBL] [Abstract][Full Text] [Related]
53. A Case of Pituitary Carcinoma Initially Diagnosed as an Ectopic Growth Hormone Producing Pituitary Adenoma with a High Ki-67 Labeling Index.
Endo T; Ogawa Y; Watanabe M; Tominaga T
J Neurol Surg A Cent Eur Neurosurg; 2018 Jan; 79(1):90-95. PubMed ID: 28586933
[TBL] [Abstract][Full Text] [Related]
54. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S; Jacob KS; Pratheesh R; Chacko AG
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[TBL] [Abstract][Full Text] [Related]
55. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
56. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country.
Gondim JA; Ferraz T; Mota I; Studart D; Almeida JP; Gomes E; Schops M
Surg Neurol; 2009 Jul; 72(1):15-9; discussion 19. PubMed ID: 18440607
[TBL] [Abstract][Full Text] [Related]
57. Delayed Remission of Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Adenectomy.
Wang Z; Guo X; Gao L; Feng C; Lian W; Deng K; Bao X; Feng M; Wang R; Xing B
World Neurosurg; 2019 Feb; 122():e1137-e1145. PubMed ID: 30447463
[TBL] [Abstract][Full Text] [Related]
58. Neuroendocrine tumor of unknown origin metastasizing to a growth hormone-secreting pituitary adenoma.
Nassiri F; Cusimano M; Rotondo F; Horvath E; Kovacs K
World Neurosurg; 2012 Jan; 77(1):201.e9-201.e12. PubMed ID: 22120409
[TBL] [Abstract][Full Text] [Related]
59. Transphenoidal surgery in acromegalic patients: anatomical considerations and potential pitfalls.
Carrabba G; Locatelli M; Mattei L; Guastella C; Mantovani G; Rampini P; Gaini SM
Acta Neurochir (Wien); 2013 Jan; 155(1):125-30; discussion 130. PubMed ID: 23180167
[TBL] [Abstract][Full Text] [Related]
60. Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly.
Varlamov EV; Wood MD; Netto JP; Thiessen J; Kim J; Lim DST; Yedinak CG; Banskota S; Cetas JS; Fleseriu M
Pituitary; 2020 Dec; 23(6):672-680. PubMed ID: 32870441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
